NCT05294627View on ClinicalTrials.gov

Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population

CompletedOBSERVATIONAL
Enrollment

380

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

November 1, 2022

Study Completion Date

October 1, 2023

Conditions
Prostate CancerLocalized Carcinoma
Interventions
DIAGNOSTIC_TEST

Stockholm3

Stockholm3 test prior to prostate biopsy. Prostate biopsy is preformed irrespective of the Stockholm3 score.

Trial Locations (1)

4031

University Hospital Basel, Urology, Basel

All Listed Sponsors
collaborator

Department of Urology, University Hospital Freiburg, Freiburg, Germany

UNKNOWN

collaborator

Department of Urology, Kantonsspital Graubünden, Chur, Switzerland

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER

NCT05294627 - Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population | Biotech Hunter | Biotech Hunter